Targeting the NF-κB pathway enhances responsiveness of mammary tumors to JAK inhibitors

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Targeting the NF-κB pathway enhances responsiveness of mammary tumors to JAK inhibitors'. Together they form a unique fingerprint.

Medicine & Life Sciences